ICON Selected by Pfizer as a Global Strategic Partner for Clinical Research and Development

by Benzinga Staff
May 26, 2011 8:35 AM | 11 seconds read |
ICON plc, ICLR today announced a strategic partnership with Pfizer Inc. PFE which will see it serve as one of two preferred providers of clinical trial implementation services.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsContractsHealth CareLife Sciences Tools & ServicesPharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!